A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis
1 Απριλίου 2024
Hirschfield. 2024: doi: 10.1056/NEJMoa2312100 Πατώντας ΕΔΩ μπορείτε να δείτε την περίληψη του άρθρου
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol- related liver disease
19 Μαρτίου 2024
Katrine Holtz Thorhauge , Georg Semmler, Stine Johansen, Katrine Prier Lindvig, Maria Kjærgaard, Johanne Kragh Hansen, Nikolaj Torp, Camilla Dalby Hansen, Peter Andersen, MSc., Benedikt
Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC
12 Μαρτίου 2024
Lee MH, Chen YT, Huang YH, Yang HI, Chen HY, Chen CJ, et al Published: February 16, 2024 DOI:https://doi.org/10.1016/j.cgh.2024.01.045 Πατώντας ΕΔΩ μπορείτε να δείτε την
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
5 Μαρτίου 2024
Stephen A Harrison, MD, Juan P Frias, MD, et al, for the HARMONY Study Group Lancet Gastroenterol Hepatol 2023, DOI:https://doi.org/10.1016/S2468-1253(23)00272-8 Πατώντας ΕΔΩ μπορείτε να δείτε
A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis
3 Μαρτίου 2024
Rinella, Mary E.; Lieu, Hsiao D.; Kowdley, Kris V., et al. Hepatology 79(3):p 674-689, March 2024. | DOI: 10.1097/HEP.0000000000000607 Πατώντας ΕΔΩ μπορείτε να δείτε την
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
26 Φεβρουαρίου 2024
Stephen A. Harrison, M.D., Pierre Bedossa, M.D., Ph.D., Cynthia D. Guy, M.D., et al for the MAESTRO-NASH Investigators N Engl J Med 2024; 390:497-509, DOI:
Risk of HCC decreases in HBV-related patients with cirrhosis acquired recompensation: A retrospective study based on Baveno VII criteria
2 Φεβρουαρίου 2024
Zhang Y, Liu X, Li S, Lin C, Ye Q, Wang Y, et al. Risk of HCC decreases in HBV-related patients with cirrhosis acquired recompensation:
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis
29 Ιανουαρίου 2024
Colapietro Jan. 2024:https://doi.org/10.1016/j.jhep.2023.09.010 Πατώντας ΕΔΩ μπορείτε να δείτε το άρθρο
Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving b-blockers+ligation to prevent re-bleeding
22 Ιανουαρίου 2024
Lorenz Balcar, Mattias Mandorfer, Virginia Hernández-Gea, ., Vincenzo La Mura, Jaime Bosch, Juan Carlos García-Pagán Journal of Hepatology, January 2024 Volume 80 Issue 1p1-172, e1-e36
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial
12 Δεκεμβρίου 2023
Thit M Kronborg , Robert Schierwagen, Kajetan Trošt, Qian Gao, Thomas Moritz, Flemming Bendtsen , Rasmus H Gantzel, Mette L Andersen, Ane S Teisner, Henning Grønbæk, Lise Hobolth , Søren Møller, Jonel Trebicka , Nina Kimer Hepatology Communications 7(12):e0332, December 2023. | DOI: 10.1097/HC9.0000000000000332 Πατώντας ΕΔΩ